148 related articles for article (PubMed ID: 35712685)
1. A Case of Recurrent Severe Hypocalcemia with Prolonged Hospitalization and Readmissions After Single Dose of Denosumab in Metastatic Prostate Cancer Patient.
Kc O; Dahal PH; Koirala M; Kothagundla CS; Al Zaghal E; Fahed R
J Community Hosp Intern Med Perspect; 2022; 12(2):60-64. PubMed ID: 35712685
[TBL] [Abstract][Full Text] [Related]
2. Severe and prolonged hypocalcemia after a single dose of denosumab for metastatic breast cancer with diffuse bone involvement without prior calcium/vitamin D supplementations.
Uhm SJ; Hall JA; Herrington JD
J Oncol Pharm Pract; 2021 Jul; 27(5):1287-1290. PubMed ID: 33081580
[TBL] [Abstract][Full Text] [Related]
3. SEVERE, PROLONGED, DENOSUMAB-INDUCED HYPOCALCEMIA WITH RECOVERY AFTER 111 DAYS OF HIGH-DOSE CALCIUM SUPPLEMENTATION.
McCaleb RV; Johnson JT
AACE Clin Case Rep; 2019; 5(1):e82-e85. PubMed ID: 31967007
[TBL] [Abstract][Full Text] [Related]
4. Hypocalcaemia following denosumab in prostate cancer: A clinical review.
Lau LH; Cliff ERS; Wong V; Wong H; Torkamani N; Eer A; Weickhardt A; Grossmann M
Clin Endocrinol (Oxf); 2020 Jun; 92(6):495-502. PubMed ID: 32017154
[TBL] [Abstract][Full Text] [Related]
5. Denosumab-induced hypocalcemia post bariatric surgery-a severe and protracted course: a case report.
Awang MH; Hatta SFWM; Mohamad AF; Ghani RA
J Med Case Rep; 2023 Mar; 17(1):73. PubMed ID: 36859300
[TBL] [Abstract][Full Text] [Related]
6. Hypocalcemia in a Patient With Metastatic Prostate Cancer From Denosumab Treatment.
Gouli S; Wang J; Patel A; Allerton J
Cureus; 2021 Aug; 13(8):e17046. PubMed ID: 34522524
[TBL] [Abstract][Full Text] [Related]
7. A RANKL Wrinkle: Denosumab-Induced Hypocalcemia.
Laskowski LK; Goldfarb DS; Howland MA; Kavcsak K; Lugassy DM; Smith SW
J Med Toxicol; 2016 Sep; 12(3):305-8. PubMed ID: 26987988
[TBL] [Abstract][Full Text] [Related]
8. Life-threatening sustained hypocalcemia following Denosumab use in metastatic prostate cancer.
Patell K; Ajay K; Al Armashi AR; Bawwab A; Ravakhah K
J Oncol Pharm Pract; 2022 Apr; 28(3):698-702. PubMed ID: 34693819
[TBL] [Abstract][Full Text] [Related]
9. Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer.
Muqeet Adnan M; Bhutta U; Iqbal T; AbdulMujeeb S; Haragsim L; Amer S
Case Rep Nephrol; 2014; 2014():565393. PubMed ID: 25054070
[TBL] [Abstract][Full Text] [Related]
10. Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review.
Marlow CF; Sharma S; Babar F; Lin J
Case Rep Oncol Med; 2018; 2018():2059364. PubMed ID: 30405927
[TBL] [Abstract][Full Text] [Related]
11. Severe hypocalcaemia following denosumab in a patient with cancer with vitamin D deficiency.
Watthanasuntorn K; Abid H; Gnanajothy R
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567243
[TBL] [Abstract][Full Text] [Related]
12. Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5.
Dave V; Chiang CY; Booth J; Mount PF
Am J Nephrol; 2015; 41(2):129-37. PubMed ID: 25790847
[TBL] [Abstract][Full Text] [Related]
13. Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.
Body JJ; von Moos R; Niepel D; Tombal B
BMC Urol; 2018 Sep; 18(1):81. PubMed ID: 30236112
[TBL] [Abstract][Full Text] [Related]
14. Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total Gastrectomy.
Iizumi S; Shimoi T; Nishikawa T; Kitano A; Sasada S; Shimomura A; Noguchi E; Yunokawa M; Yonemori K; Shimizu C; Fujiwara Y; Tamura K
Intern Med; 2017 Nov; 56(21):2879-2882. PubMed ID: 28943574
[TBL] [Abstract][Full Text] [Related]
15. Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery.
Schmucker AM; Green DE; Montemuro PM
Case Rep Endocrinol; 2020; 2020():8833723. PubMed ID: 32774945
[TBL] [Abstract][Full Text] [Related]
16. Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer.
Milat F; Goh S; Gani LU; Suriadi C; Gillespie MT; Fuller PJ; Teede HJ; Strickland AH; Allan CA
Bone; 2013 Aug; 55(2):305-8. PubMed ID: 23685544
[TBL] [Abstract][Full Text] [Related]
17. Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.
Autio KA; Farooki A; Glezerman IG; Chan A; Schneider CW; Barr HC; Seyboth BM; Kampel LJ; Danila DC; Rathkopf DE; Slovin SF; Scher HI; Morris MJ
Clin Genitourin Cancer; 2015 Aug; 13(4):e305-e309. PubMed ID: 25559408
[No Abstract] [Full Text] [Related]
18. Severe and refractory hypocalcaemia secondary to osteoblastic bone metastases in bladder signet ring carcinoma: A case report and literature review.
Zeng W; Swee DS
Medicine (Baltimore); 2022 Jul; 101(26):e29731. PubMed ID: 35776989
[TBL] [Abstract][Full Text] [Related]
19. Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?
Tsvetov G; Amitai O; Shochat T; Shimon I; Akirov A; Diker-Cohen T
Osteoporos Int; 2020 Apr; 31(4):655-665. PubMed ID: 31838550
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency.
Watkins KR; Rogers JE; Atkinson B
Support Care Cancer; 2015 Jun; 23(6):1657-62. PubMed ID: 25421444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
